Goldman Sachs
-
Two Chinese firms have raised more than $1.5bn between them to bring hope of a revival in Asia's equity-linked market -
Chinese biopharma firm parks over 70% of the IPO with cornerstones
-
The German development bank has now funded 83% of its €90bn funding target
-
The $675m deal ticked many boxes for both the issuer and investors and could signal a rebound in appetite
-
Issuer maxes out on its size target for euro benchmark
-
-
Chinese biopharmaceutical company prepares to test investor appetite for listing
-
Construction materials firm gathers demand of more than six times deal size at launch for summer triple trancher
-
More than €20bn of corp bonds possible this month as tone improves despite dwindling liquidity
-
The electric car components maker is preparing to go public on the Milan Stock Exchange
-
Europe's largest ever new listing set to go ahead as Oliver Blume prepares to lead Porsche and Volkswagen
-
Goldman's results this week were a harbinger of what is to come for jobs in the equity capital markets
